Publication | Open Access

Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

Chemotherapy Versus ChemotherapyOncologyEsophageal CancerGastrointestinal OncologyClinical TrialsFirst-line TreatmentCancer TreatmentMedicineRadiation OncologyAdvanced Oesophageal CancerHealth Sciences